Income Statement
Balance Sheet
Cash Flow
| Line Item | Q4 2025Nov 30, 2025 | Q3 2025Aug 31, 2025 | Q2 2025May 31, 2025 | Q1 2025Feb 28, 2025 | Q4 2024Nov 30, 2024 |
|---|---|---|---|---|---|
| Total Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling General And Administration | 789,601 | -77,278 | 250,902 | 71,281 | 82,913 |
| General And Administrative Expense | 789,601 | -77,278 | 250,902 | 71,281 | 82,913 |
| Research And Development | -- | 77,635 | 0.00 | 0.00 | 0.00 |
| Other Operating Expenses | 41,817 | 123,714 | 37,659 | 43,377 | 33,151 |
| Operating Expense | 831,418 | 46,436 | 288,561 | 114,658 | 116,064 |
| Operating Income | -831,418 | -46,436 | -288,561 | -114,658 | -116,064 |
| EBIT | -831,418 | -46,436 | -288,561 | -114,658 | -116,064 |
| Interest Expense | -- | -- | -- | -- | -- |
| Interest Expense Non Operating | -- | -- | -- | -- | -- |
| Net Interest Income | -- | -- | -- | -- | -- |
| Other Income Expense | 17,066 | -312,836 | -198,032 | 392,111 | 393,355 |
| Other Non Operating Income Expenses | -- | -- | -- | -- | 69,018 |
| Special Income Charges | 0.00 | -308,218 | -935.00 | 318,693 | 69,018 |
| Gain On Sale Of Security | 17,066 | -4,618 | -197,097 | 73,418 | 324,337 |
| Pretax Income | -814,352 | -359,272 | -486,593 | 277,453 | 277,291 |
| Tax Effect Of Unusual Items | 0.00 | 0.00 | 0.00 | 58,817 | 59,003 |
| Net Income From Continuing And Discontinued Operation | -814,352 | -359,272 | -486,593 | 277,453 | 277,291 |
| Net Income From Continuing Operation Net Minority Interest | -814,352 | -359,272 | -486,593 | 277,453 | 277,291 |
| Net Income Including Noncontrolling Interests | -814,352 | -359,272 | -486,593 | 277,453 | 277,291 |
| Net Income Common Stockholders | -814,352 | -359,272 | -486,593 | 277,453 | 277,291 |
| Net Income | -814,352 | -359,272 | -486,593 | 277,453 | 277,291 |
| EBITDA | -831,418 | -46,436 | -288,561 | -114,658 | -116,064 |
| Normalized EBITDA | -848,484 | 266,400 | -90,529 | -506,769 | -509,419 |
| Basic EPS | -0.01 | -- | 0.00 | 0.00 | 0.00 |
| Diluted EPS | -0.01 | -- | 0.00 | 0.00 | 0.00 |
| Basic Average Shares | 155.5M | -- | 147.5M | 147.5M | 147.5M |
| Diluted Average Shares | 155.5M | -- | 147.5M | 147.5M | 147.5M |
| Total Unusual Items | 17,066 | -312,836 | -198,032 | 392,111 | 393,355 |
| Total Unusual Items Excluding Goodwill | 17,066 | -312,836 | -198,032 | 392,111 | 393,355 |
| Tax Rate For Calcs | 0.00 | 0.00 | 0.00 | 0.15 | 0.15 |
| Normalized Income | -831,418 | -46,436 | -288,561 | -55,841 | -57,061 |
| Diluted NI Availto Com Stockholders | -814,352 | -359,272 | -486,593 | 277,453 | 277,291 |
| Gain On Sale Of Ppe | -- | -- | -- | -- | -- |
| Impairment Of Capital Assets | -- | 336,718 | 935.00 | -318,693 | -- |
| Net Income Continuous Operations | -814,352 | -359,272 | -486,593 | 277,453 | 277,291 |
| Net Non Operating Interest Income Expense | -- | -- | -- | -- | -- |
| Other Gand A | 242,306 | 113,326 | 73,300 | 70,321 | 82,095 |
| Other Special Charges | -- | -28,500 | -- | -- | -69,018 |
| Salaries And Wages | 547,295 | -190,604 | 177,602 | 960.00 | 818.00 |
| Total Expenses | 831,418 | 46,436 | 288,561 | 114,658 | 116,064 |
| Total Operating Income As Reported | -848,812 | -45,714 | -278,100 | -124,904 | -136,553 |
| Line Item | Q4 2025Nov 30, 2025 | Q3 2025Aug 31, 2025 | Q2 2025May 31, 2025 | Q1 2025Feb 28, 2025 | Q4 2024Nov 30, 2024 |
|---|---|---|---|---|---|
| Cash And Cash Equivalents | 22,748 | 182,135 | 17,383 | 42,313 | 33,787 |
| Cash Cash Equivalents And Short Term Investments | 175,408 | 316,865 | 196,744 | 489,366 | 707,102 |
| Cash Financial | 22,748 | 182,135 | 17,383 | 42,313 | 33,787 |
| Other Short Term Investments | 152,660 | 134,730 | 179,361 | 447,053 | 673,315 |
| Receivables | 23,497 | 18,483 | 360,640 | 382,593 | 370,712 |
| Prepaid Assets | 31,495 | 14,437 | 72,900 | 17,290 | 8,761 |
| Current Assets | 230,400 | 349,785 | 630,284 | 889,249 | 1.1M |
| Net PPE | 1.4M | 1.4M | 1.4M | 1.4M | 1.4M |
| Total Non Current Assets | 1.4M | 1.4M | 1.4M | 1.4M | 1.4M |
| Total Assets | 1.7M | 1.8M | 2.0M | 2.3M | 2.4M |
| Accounts Payable | 364,809 | 332,265 | 344,291 | 339,912 | 489,139 |
| Payables | 1.2M | 971,477 | 1.0M | 982,786 | 1.1M |
| Payables And Accrued Expenses | 1.6M | 1.4M | 1.1M | 1.1M | 1.5M |
| Current Accrued Expenses | 404,056 | 423,842 | 76,871 | 71,466 | 397,735 |
| Other Current Liabilities | -- | -- | -- | -- | -- |
| Current Liabilities | 1.6M | 1.4M | 1.1M | 1.1M | 1.5M |
| Total Non Current Liabilities Net Minority Interest | 27,938 | 27,485 | 27,566 | 28,763 | 28,003 |
| Total Liabilities Net Minority Interest | 1.6M | 1.4M | 1.1M | 1.1M | 1.6M |
| Common Stock | 29.5M | 29.5M | 28.5M | 28.5M | 28.5M |
| Capital Stock | 29.5M | 29.5M | 28.5M | 28.5M | 28.5M |
| Retained Earnings | -35.2M | -34.4M | -33.7M | -33.2M | -33.5M |
| Gains Losses Not Affecting Retained Earnings | 5.8M | 5.2M | 5.8M | 5.6M | 5.6M |
| Common Stock Equity | 68,671 | 362,228 | 858,195 | 1.2M | 888,774 |
| Stockholders Equity | 68,671 | 362,228 | 858,195 | 1.2M | 888,774 |
| Total Equity Gross Minority Interest | 68,671 | 362,228 | 858,195 | 1.2M | 888,774 |
| Total Capitalization | 68,671 | 362,228 | 858,195 | 1.2M | 888,774 |
| Net Tangible Assets | 68,671 | 362,228 | 858,195 | 1.2M | 888,774 |
| Tangible Book Value | 68,671 | 362,228 | 858,195 | 1.2M | 888,774 |
| Working Capital | -1.3M | -1.0M | -477,197 | -165,003 | -442,675 |
| Invested Capital | 68,671 | 362,228 | 858,195 | 1.2M | 888,774 |
| Share Issued | 155.5M | 155.3M | 147.5M | 147.5M | 147.5M |
| Ordinary Shares Number | 155.5M | 155.3M | 147.5M | 147.5M | 147.5M |
| Dueto Related Parties Current | 802,099 | 639,212 | 686,319 | 642,874 | 642,376 |
| Long Term Provisions | 27,938 | 27,485 | 27,566 | 28,763 | 28,003 |
| Other Equity Interest | -- | -- | 228,176 | 227,116 | 226,156 |
| Other Receivables | 23,497 | 18,483 | 360,640 | 382,593 | 370,712 |
| Line Item | Q4 2025Nov 30, 2025 | Q3 2025Aug 31, 2025 | Q2 2025May 31, 2025 | Q1 2025Feb 28, 2025 | Q4 2024Nov 30, 2024 |
|---|---|---|---|---|---|
| Operating Cash Flow | -147,491 | -141,834 | -83,059 | -299,899 | -41,384 |
| Cash Flow From Continuing Operating Activities | -147,491 | -141,834 | -83,059 | -299,899 | -41,384 |
| Stock Based Compensation | 547,295 | -190,604 | 177,602 | 960.00 | 818.00 |
| Change In Working Capital | 151,180 | 87,203 | 3,830 | -167,309 | 106,081 |
| Change In Receivables | -5,014 | 1,203 | 7,147 | -2,475 | -2,070 |
| Change In Payables And Accrued Expense | 173,252 | 27,537 | 52,293 | -156,305 | 102,872 |
| Other Non Cash Items | -- | -28,500 | 0.00 | 0.00 | -69,018 |
| Net PPE Purchase And Sale | -- | -- | -- | -- | -- |
| Sale Of Investment | 16,530 | 39,291 | 60,134 | 309,926 | 39,030 |
| Net Investment Purchase And Sale | 16,530 | 39,291 | 60,134 | 309,926 | 39,030 |
| Investing Cash Flow | 14,604 | -80,914 | 58,129 | 308,425 | 39,030 |
| Cash Flow From Continuing Investing Activities | 14,604 | -80,914 | 58,129 | 308,425 | 39,030 |
| Financing Cash Flow | -26,500 | -- | -- | -- | 0.00 |
| Cash Flow From Continuing Financing Activities | -26,500 | -- | -- | -- | 0.00 |
| Effect Of Exchange Rate Changes | -- | -- | -- | -- | -- |
| Changes In Cash | -159,387 | 164,752 | -24,930 | 8,526 | -2,354 |
| Beginning Cash Position | 182,135 | 17,383 | 42,313 | 33,787 | 36,141 |
| End Cash Position | 22,748 | 182,135 | 17,383 | 42,313 | 33,787 |
| Free Cash Flow | -147,491 | -141,834 | -83,059 | -299,899 | -41,384 |
| Asset Impairment Charge | -- | 336,718 | 935.00 | -- | -- |
| Change In Prepaid Assets | -17,058 | 58,463 | -55,610 | -8,529 | 5,279 |
| Gain Loss On Investment Securities | 14,970 | 55,209 | 64,921 | 116,993 | 27,120 |
| Gain Loss On Sale Of PPE | -- | -- | -- | -- | -- |
| Net Foreign Currency Exchange Gain Loss | 2,846 | 7,281 | 13,609 | -8,646 | -11,730 |
| Net Income From Continuing Operations | -814,352 | -359,272 | -486,593 | 277,453 | 277,291 |
| Net Other Financing Charges | -39,000 | -- | -- | -- | -- |
| Net Other Investing Changes | -1,926 | -120,205 | -2,005 | -- | -- |
| Operating Gains Losses | 17,816 | 62,490 | 78,530 | 108,347 | 15,390 |
| Proceeds From Stock Option Exercised | 12,500 | -- | -- | -- | 0.00 |
| Sale Of PPE | -- | -- | -- | -- | -- |
| Unrealized Gain Loss On Investment Securities | -49,430 | -49,869 | 142,637 | -200,657 | -371,946 |